Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate

Basit Öğe Kaydı
dc.contributor.authorBahceci, Mithat
dc.contributor.authorPasa, Semir
dc.contributor.authorAkay, Hatice O.
dc.contributor.authorTuzcu, Alpaslan
dc.contributor.authorTumer, Cemil
dc.contributor.authorGokalp, Deniz
dc.date.accessioned2024-04-24T16:11:31Z
dc.date.available2024-04-24T16:11:31Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractBaseline and stimulated nitric oxide (NO) levels were higher, whereas baseline arterial diameter, FMD-stimulated NO increment, and arterial dilatation ratio were lower in Sheehan syndrome (SS) patients than in control subjects. After combination therapy consisting of prednisolone, L-thyroxine, and conjugated estrogen, baseline and stimulated NO levels of SS remained as high, but FMID-stimulated NO, NO increment ratio, and arterial dilatation ratio increased with treatment. (Fertil Steril (R) 2008;89:995-7. (c) 2008 by American Society for Reproductive Medicine.)en_US
dc.identifier.doi10.1016/j.fertnstert.2007.04.014
dc.identifier.endpage997en_US
dc.identifier.issn0015-0282
dc.identifier.issn1556-5653
dc.identifier.issue4en_US
dc.identifier.pmid17582407
dc.identifier.scopus2-s2.0-41749123745
dc.identifier.scopusqualityQ1
dc.identifier.startpage995en_US
dc.identifier.urihttps://doi.org/10.1016/j.fertnstert.2007.04.014
dc.identifier.urihttps://hdl.handle.net/11468/15418
dc.identifier.volume89en_US
dc.identifier.wosWOS:000255250100036
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofFertility and Sterility
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword]en_US
dc.titleSerum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetateen_US
dc.titleSerum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate
dc.typeEditorialen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu